The controlled release cell consists of a central component containing R-Lansoprazol and a soluble controlled release coating, depending on the copolymer pH and L (Div. Sol) selected from the metabolic acid. 2051-2003).

• 收藏
• 分享

专利权人:

TAKEDA PHARMACEUTICAL COMPANY LIMITED.

发明人:

AKIYAMA YOHKO, KURASAWA TAKASHI, BANDO HIROTO, NAGAHARA NAO KI.

申请号：

CL2012000406

公开号：

CL2012000406A1

申请日:

2012.02.16

申请国别(地区):

CL

年份:

2012

代理人:

摘要：

Tablet, granule or pellet Fine controlled release which includes a Central Particle containing lansoprazole or a derivative thereof,And a layer of coating controlled release soluble pH dependent comprising at least one class of polymeric Substances (Div. Sun. No. 2051 - 03).GRÁNULO DE LIBERACIÓN CONTROLADA QUE COMPRENDE UNA PARTÍCULA CENTRAL QUE CONTIENE AL ISÓMERO R-LANSOPRAZOL Y UNA CAPA DE RECUBRIMIENTO DE LIBERACIÓN CONTROLADA SOLUBLE DEPENDIENTE DEL PH SELECCIONADA DE COPOLÍMEROS S Y L DEL ÁCIDO METACRÍLICO (DIV. SOL. Nº 2051-2003).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/